Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report

BACKGROUND: Patients undergone kidney transplantation present higher risk of Urothelial Carcinoma (UC) development and represent a subgroup of special interest. To date, vinflunine is the only drug approved in Europe for the treatment of advanced UC after failure of platinum-based chemotherapy. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordi, Paola, Tiseo, Marcello, Baldari, Giorgio, Buti, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983020/
https://www.ncbi.nlm.nih.gov/pubmed/27519420
http://dx.doi.org/10.1186/s12885-016-2666-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983020/
https://www.ncbi.nlm.nih.gov/pubmed/27519420
http://dx.doi.org/10.1186/s12885-016-2666-6

Ejemplares similares